Literature DB >> 25293586

Effects of weight regain following intentional weight loss on glucoregulatory function in overweight and obese adults with pre-diabetes.

Kristen M Beavers1, L Douglas Case2, Caroline S Blackwell3, Jeffery A Katula4, David C Goff5, Mara Z Vitolins3.   

Abstract

OBJECTIVE: To assess the extent to which initial, intentional weight loss-associated improvements in glucose tolerance and insulin action are diminished with weight regain.
METHODS: 138 overweight and obese (BMI: 32.4±3.9kg/m(2)), adults (59.0±9.7 years), with pre-diabetes were followed through a 6-month weight loss intervention and subsequent 18-month weight maintenance period, or usual care control condition. Longitudinal change in weight (baseline, 6, 24 months) was used to classify individuals into weight pattern categories (Loser/Maintainer (LM), n= 50; Loser/Regainer (LR), n=51; and Weight Stable (WS), n=37). Fasting plasma glucose (FPG), insulin, and insulin resistance (HOMA-IR) were measured at baseline, 6, 12, 18 and 24 months and model adjusted changes, by weight pattern category, were assessed.
RESULTS: LMs and LRs lost 8.3±4.7kg (8.7±4.5%) and 9.6±4.7kg (10.2±4.7%) during the first 6 months, respectively. LM continued to lose 1.1±3.4kg over the next 18 months (9.9±6.5% reduction from baseline; p<0.05), while LRs regained 6.5±3.7kg (3.3±5.3% reduction from baseline; p<0.05). Weight change was directly associated with change in all DM risk factors (all p<0.01). Notably, despite an absolute reduction in body weight (from baseline to 24 months) achieved in the LR group, 24-month changes in FPG, insulin, and HOMA-IR did not differ between WS and LR groups. Conversely, LM saw sustained improvements in all measured DM risk factors.
CONCLUSIONS: Significant weight loss followed by weight loss maintenance is associated with sustained improvements in FPG, insulin, and HOMA-IR; conversely, even partial weight regain is associated with regression of initial improvements in these risk factors towards baseline values.
Copyright © 2014 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fasting plasma glucose; Fasting plasma insulin; Pre-diabetes; Weight loss; Weight regain

Mesh:

Year:  2014        PMID: 25293586      PMCID: PMC4385513          DOI: 10.1016/j.orcp.2014.09.003

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  21 in total

1.  Intentional weight loss and 13-year diabetes incidence in overweight adults.

Authors:  Julie C Will; David F Williamson; Earl S Ford; Eugenia E Calle; Michael J Thun
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

Review 2.  Long-term weight loss maintenance.

Authors:  Rena R Wing; Suzanne Phelan
Journal:  Am J Clin Nutr       Date:  2005-07       Impact factor: 7.045

3.  Weight regain in U.S. adults who experienced substantial weight loss, 1999-2002.

Authors:  Edward C Weiss; Deborah A Galuska; Laura Kettel Khan; Cathleen Gillespie; Mary K Serdula
Journal:  Am J Prev Med       Date:  2007-07       Impact factor: 5.043

4.  Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Douglas Befroy; Michael Lehrke; Rosa E Hendler; Gerald I Shulman
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

5.  Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight.

Authors:  C Weyer; K Hanson; C Bogardus; R E Pratley
Journal:  Diabetologia       Date:  2000-01       Impact factor: 10.122

6.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

7.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

Review 8.  Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992.

Authors: 
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

9.  Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial.

Authors:  Pilvikki Absetz; Raisa Valve; Brian Oldenburg; Heikki Heinonen; Aulikki Nissinen; Mikael Fogelholm; Vesa Ilvesmäki; Martti Talja; Antti Uutela
Journal:  Diabetes Care       Date:  2007-06-22       Impact factor: 19.112

10.  Rate of weight gain, weight fluctuation, and incidence of NIDDM.

Authors:  R L Hanson; K M Narayan; D R McCance; D J Pettitt; L T Jacobsson; P H Bennett; W C Knowler
Journal:  Diabetes       Date:  1995-03       Impact factor: 9.461

View more
  7 in total

1.  Long-term Weight Loss Maintenance in the Continuation of a Randomized Diabetes Prevention Translational Study: The Healthy Living Partnerships to Prevent Diabetes (HELP PD) Continuation Trial.

Authors:  Mara Z Vitolins; Caroline S Blackwell; Jeffrey A Katula; Scott P Isom; L Douglas Case
Journal:  Diabetes Care       Date:  2019-07-11       Impact factor: 19.112

2.  Comparison among criteria to define successful weight-loss maintainers and regainers in the Action for Health in Diabetes (Look AHEAD) and Diabetes Prevention Program trials.

Authors:  Samantha E Berger; Gordon S Huggins; Jeanne M McCaffery; Alice H Lichtenstein
Journal:  Am J Clin Nutr       Date:  2017-10-18       Impact factor: 7.045

3.  GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice.

Authors:  Ricardo J Samms; Michael E Christe; Kyla Al Collins; Valentina Pirro; Brian A Droz; Adrienne K Holland; Jessica L Friedrich; Samantha Wojnicki; Debra L Konkol; Richard Cosgrove; Ellen Ps Conceição Furber; Xiaoping Ruan; Libbey S O'Farrell; Annie M Long; Mridula Dogra; Jill A Willency; Yanzhu Lin; Liyun Ding; Christine C Cheng; Over Cabrera; Daniel A Briere; Jorge Alsina-Fernandez; Ruth E Gimeno; Julie S Moyers; Tamer Coskun; Matthew P Coghlan; Kyle W Sloop; William C Roell
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

4.  The impact of supervised weight loss and intentional weight regain on sex hormone binding globulin and testosterone in premenopausal women.

Authors:  Mira Aubuchon; Ying Liu; Gregory F Petroski; Tom R Thomas; Alex J Polotsky
Journal:  Syst Biol Reprod Med       Date:  2016-05-18       Impact factor: 3.061

5.  Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history.

Authors:  L D Clamp; D J Hume; E V Lambert; J Kroff
Journal:  Nutr Diabetes       Date:  2017-06-19       Impact factor: 5.097

6.  A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss.

Authors:  Maria J Pereira; Per Lundkvist; Prasad G Kamble; Joey Lau; Julian G Martins; C David Sjöström; Volker Schnecke; Anna Walentinsson; Eva Johnsson; Jan W Eriksson
Journal:  Diabetes Ther       Date:  2018-06-13       Impact factor: 2.945

7.  Risk of developing pre-diabetes or diabetes over time in a cohort of Mexican health workers.

Authors:  Yvonne N Flores; Samantha Toth; Catherine M Crespi; Paula Ramírez-Palacios; William J McCarthy; Arely Briseño-Pérez; Víctor Granados-García; Jorge Salmerón
Journal:  PLoS One       Date:  2020-03-25       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.